DAY ONE BIOPHARMACEUTICALS I (DAWN) Stock Income Statement
NASDAQ:DAWN - Nasdaq - US23954D1090 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 161.92M | 131.16M | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | 0.00 | 0.00 | -97.89M | |||
| Cost Of Goods | 8.16M | 5.28M | N/A | N/A | N/A | |||
| Gross Profit | 153.76M | 125.88M | N/A | N/A | N/A | |||
| Operating Expenses | 345.33M | 343.15M | 206.06M | 146.91M | 72.74M | |||
| Research and Development | 227.11M | 227.70M | 130.52M | 85.62M | 43.58M | |||
| Selling, General, and Administrative Expenses | 118.22M | 115.45M | 75.54M | 61.29M | 29.16M | |||
| Operating Income | -191.57M | -217.27M | -206.06M | -146.91M | -72.74M | |||
| Interest Income/Expense | 20.43M | 19.70M | 17.19M | 4.75M | 0.00 | |||
| Other Income/Expense | 1.20M | 1.22M | -40.00K | -20.00K | -20.00K | |||
| Non Recurring Items | N/A | 108.00M | N/A | N/A | N/A | |||
| Income Before Taxes | -61.94M | -88.35M | -188.92M | -142.18M | -72.75M | |||
| Income Tax | 7.14M | 7.14M | N/A | N/A | N/A | |||
| Net Income | -69.08M | -95.50M | -188.92M | -142.18M | -170.64M | |||
| EBITDA | -188.67M | -215.24M | -205.68M | -146.85M | -72.72M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.66 | -1.02 | -2.37 | -2.17 | -4.62 | |||
| Non GAAP EPS | -1.41 | -1.78 | -2.38 | -2.17 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 94.96% | 95.98% | N/A | N/A | N/A | |||
| Profit Margin | -42.66% | -72.81% | N/A | N/A | N/A | |||
| Operating Profit Margin | -118.31% | -165.65% | N/A | N/A | N/A | |||
All data in USD